0.00Open0.10Pre Close0 Volume2 Open Interest50.00Strike Price0.00Turnover327.41%IV24.92%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.0488Delta0.0196Gamma401.08Leverage Ratio-0.4395Theta0.0000Rho19.59Eff Leverage0.0016Vega
Amphastar Pharmaceuticals Stock Discussion
✨Bioequivalent and therapeutically equivalent to $TEVA ProAir® HFA Inhalation Aerosol
» ANDA approval
» Indication: Tx or prevention of bronchospasm 🫁
» Product launch in Q3 '24
No comment yet